(1)
Balakrishna, V. A.; Police, A.; Hiremath, R.; Raj, A.; Sulochana, S. P.; Chandrasekhar, D. V.; Mohd, Z.; Bhamidipati, R. K.; Mullangi, R. Preclinical Assessment of Ulixertinib, a Novel ERK1/2 Inhibitor. ADMET DMPK 2017, 5, 212-223.